Recent Finacing
Recent Raise
ExPLoRNA Therapeutics develops novel 5' mRNA cap analogs to enhance protein expression and enable lower-dose vaccines and mAb production, testing effects in clinically validated Acuitas lipid nanoparticle formulations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor